Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study of a Once Daily Dose of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects

NCT00642291 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT00642291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00642291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study of a Once Daily Dose of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects
Lead sponsor
Gilead Sciences
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2002
Completion date
July 31, 2004
Enrollment
16 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections